Research letterDupilumab for hand eczema
References (5)
- et al.
Efficacy and safety of dupilumab for the treatment of adult atopic dermatitis: a meta-analysis of randomized clinical trials
J Allergy Clin Immunol
(2017) - et al.
Hand eczema–prognosis and consequences: a 7-year follow-up study
Br J Dermatol
(2014)
There are more references available in the full text version of this article.
Cited by (0)
Funding sources: None.
Discolosure: Dr Zirwas has received remuneration from the following companies for consulting, speaking, or conducting clinical trials: Regeneron, Sanofi-Genzyme, Fitbit, Genentech, Novartis, L'Oreal, Menlo Therapeutics, AsepticMD, Leo, Janssen, Incyte, Foamix, DS Biopharma, and UCB.
Reprints not available from the author.
© 2018 by the American Academy of Dermatology, Inc.